Ocular Therapeutix, Inc. (OCUL) Operating cash flow 2016–2025
Ocular Therapeutix, Inc. (OCUL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$204.9MFY2025 · since FY2016: -$34.0M → -$204.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$204.9M | -52.1% |
| FY2024 | -$134.7M | -91.8% |
| FY2023 | -$70.2M | -17.8% |
| FY2022 | -$59.6M | +9.1% |
| FY2021 | -$65.5M | -22.4% |
| FY2020 | -$53.6M | +31.0% |
| FY2019 | -$77.6M | -57.6% |
| FY2018 | -$49.2M | +2.5% |
| FY2017 | -$50.5M | -48.4% |
| FY2016 | -$34.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice